Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sernova Corp
(OP:
SEOVF
)
0.1743
UNCHANGED
Streaming Delayed Price
Updated: 11:04 AM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.1743
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.1743
Today's Range
0.1743 - 0.1743
52wk Range
0.1525 - 0.6142
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Sernova Provides Positive Clinical and Platform Portfolio Update
April 02, 2024
With recent positive findings in post-surgical hypothyroidism large animal study, Sernova anticipates filing an Investigational New Drug (IND) application in 2024
Via
TheNewswire.com
Sernova Announces Peer Reviewed Publication Demonstrating Safety and Efficacy of a Novel Cell Pouch Cell Therapy Approach for Treatment of Severe Hemophilia A
January 20, 2022
LONDON, ONTARIO – TheNewswire - January 20, 2022 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH), a clinical-stage regenerative medicine and cell therapy therapeutics company developing a...
Via
TheNewswire.com
Performance
YTD
-68.16%
-68.16%
1 Month
-12.85%
-12.85%
3 Month
-28.86%
-28.86%
6 Month
-56.96%
-56.96%
1 Year
-68.81%
-68.81%
More News
Read More
Sernova to Present Corporate Update at Canaccord Genuity's 41st Annual Growth Conference
August 09, 2021
Via
TheNewswire.com
Exposures
COVID-19
Sernova Announces 2021 Annual Meeting Results: Shareholders Approve Resolutions with Overwhelming Majority
July 05, 2021
Via
TheNewswire.com
Exposures
COVID-19
Industry Veteran Frank Shannon Joins Sernova as VP Clinical Development and Regulatory Affairs
June 30, 2021
Via
TheNewswire.com
Exposures
COVID-19
Sernova's Principal Investigator Presents Interim Data and Positive Patient Outcomes of Phase I/II T1D Study at the American Diabetes Association 81st Scientific Sessions
June 28, 2021
Via
TheNewswire.com
Exposures
COVID-19
Sernova's Principal Investigator Presents Positive New Data from Ongoing Type 1 Diabetes (T1D) Clinical Trial at ATC 2021 Virtual Connect Conference
June 07, 2021
Via
TheNewswire.com
Exposures
COVID-19
Sernova Announces American Transplant Congress 2021 Virtual Connect Abstract Presentation
June 01, 2021
Via
TheNewswire.com
Exposures
COVID-19
Sernova to Present at Global Partnership Family Office -- HealthCare & Biotechnology TSX Showcase
May 17, 2021
Via
TheNewswire.com
Sernova Announces the Nomination of Seasoned Pharma Executive Dr. Mohammad Azab to its Board of Directors
May 04, 2021
Via
TheNewswire.com
Topics
Retirement
Exposures
Pension
Sernova KOL Event Highlights Novel Cell Therapy Approach for the Potential Treatment of Thyroid Disease
April 28, 2021
Via
TheNewswire.com
Sernova to Host a Virtual Key Opinion Leader Event on Thyroid Disease and the Potential for its Cell Therapy as a Novel Treatment Approach
April 21, 2021
Via
TheNewswire.com
Sernova Appoints Internationally Renowned Thyroid Disease Expert Dr. Sam Wiseman to its Scientific Advisory Board
April 14, 2021
Via
TheNewswire.com
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.